AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 174 min read$BDCO

BLUE DOLPHIN ENERGY CO (BDCO): Results of Operations and Financial Condition

BLUE DOLPHIN ENERGY CO (BDCO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_967513.htm EXHIBIT 99.1 BDCO EARNINGS RLS DATED AUGUST 17, 2026 ex_967513.htm Exhibit 99.1 PRESS RELEASE FOR IMMEDIATE RELEASE BLUE DOLPHIN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS ● Total gross profit of $25.1 million and $45.7 million for the three and six mon

Original reporting
SEC EDGAR 8-K
Published Aug 17, 2026, 1:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 1:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$BDCO
Bullish
medium confidence
Mentioned
$BDCO
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BDCOBullishMed
01

Why it matters

The filing shows a major swing from prior-year losses to substantial net income, with gross profit and EBITDA rising sharply and liquidity jumping to $31.7M cash and restricted cash at June 30, 2026.

02

Market read

Traders can update expectations for profitability and balance-sheet strength based on the disclosed earnings rebound and liquidity increase.

03

What to watch

The release does not quantify operating cash flow, leverage, or forward guidance in the provided text, so sustainability and capital needs remain unclear.

Relevance 7/10Novelty 8/10Timing: filed pre-market/early trading today (Aug 17, 2026) with Q2 and 6M results

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting Blue Dolphin’s Q2 2026 and six-month ended June 30, 2026 financial results.

Company-level read

Ticker impact

$BDCOBullishMedium confidence
Context

Blue Dolphin reported Q2 2026 net income of $17.7M and EBITDA of $24.4M, versus net loss and EBITDA near zero in Q2 2025.

Expected impact

Near-term upside bias as traders re-rate profitability and liquidity improvement, though OTC liquidity can limit follow-through.

Evidence & confidence

The filing provides concrete quarter and six-month income, gross profit, EBITDA, and liquidity figures, which are direct inputs to valuation and risk for this issuer.

Market effects

Sector

Signals improved downstream refining economics or execution for a Gulf Coast independent refiner, but impact is company-specific given the small scale.

Regional

Limited broader read-through; results are tied to Eagle Ford operations and storage/tolling mix in Texas.

Global

No direct global linkage beyond general oil price/geopolitical volatility referenced in management commentary.

Counterpoint

What could challenge this read

The year-over-year improvement may reflect temporary margin/tolling conditions rather than durable structural earnings power.

Key entities

  • issuer
    Blue Dolphin Energy Company

    Independent refiner and marketer operating in the Eagle Ford Shale region, filing Q2 2026 results on Form 8-K.

  • executive
    Jonathan P. Carroll

    CEO, quoted attributing results to disciplined execution amid geopolitical and market volatility.

Read at source← All news

Related articles

AUG 17
$CRGOMedAI 8/10

Why is Freightos stock soaring today?

Freightos (CRGO) shares rose about 11.5% after the freight booking and payments platform reported Q2 revenue of $7.7M versus LSEG-estimated $7.3M. The company posted a narrower loss of 3 cents per share. It reported record gross booking value of $422M (+33% YoY) and trimmed its full-year revenue outlook to $30.4M-$31.0M.

investing.com4 min
AUG 17
$LONAMed

LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances

LeonaBio (NASDAQ:LONA) reported a Q2 loss of $0.80 per share, smaller than analysts’ $1.12 forecast. Net loss rose to $19.0 million from $7.0 million a year earlier. Phase 3 ELAINE-3 enrollment nears 600 target, with 495 patients enrolled and topline results expected in H2 2027. Cash fell to $51.1 million from $88.3 million.

yahoo.com4 min
AUG 17
$JSPRMed

Jasper Therapeutics beats Q2 expectations but shares fall after results

Jasper Therapeutics (NASDAQ:JSPR) reported Q2 2026 adjusted loss of $0.10 per share, better than the $0.28 consensus, and a net loss of $2.8 million. Shares fell 4.24% pre-market. In July, Jasper completed an all-stock acquisition of Kira Pharmaceuticals and a $132 million private placement, extending its funding runway into 2H 2028. Pipeline updates include KP-104 Phase 2 interim data in Q4 2026 and briquilimab and KP-701 milestones in early 2027.

yahoo.com4 min
AUG 17
$PPSIMed

PIONEER POWER SOLUTIONS, INC. (PPSI): Results of Operations and Financial Condition

PIONEER POWER SOLUTIONS, INC. (PPSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Pioneer Power Announces Financial Results for Second Quarter 2026 and Provides a Business Update ● Backlog Grew 32% Sequentially to $18.4 Million ● Projecting Revenue of Approximately $15 Million in Second Half of 2026, Representing More

SEC EDGAR 8-K6 min